Name

BlueSkeye AI

Legal name

BLUESKEYE AI Ltd

Website

https://blueskeye.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

AI Emotional Intelligence Software (Face & Voice Behaviour Analysis)

NAICS

Computer Systems Design and Related Services (54151), Home Health Care Services (621610)

SIC

Services-Prepackaged Software (7372), Services-Health Services (8000)

akta.pro primary industry

Autonomous Driving & ADAS Perception (HDAAAEAI)

akta.pro secondary industry

AI/Analytics for RPM (Risk Stratification, Alerts, Predictive) (HLACAFAM)

Keywords

• Facial behaviour analysis
• Emotional intelligence software
• Automotive driver monitoring
• Social robotics SDK
• Mental health biomarkers

Headquarters

HQ city

Nottingham

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Automotive SDK Licensing / OEM Software Supply: B-Automotive SDK licensed to global automotive OEMs and Tier 1 suppliers as a production-grade software component integrated into ADAS and Intelligent Cockpit vehicle programmes. Revenue is generated through design-win fees, NRE (non-recurring engineering) charges, and per-unit or annual licensing fees tied to vehicle production programmes. The May 2026 production contract with a global OEM represents the first major commercial validation of this model.
2. Social Robotics SDK Licensing: B-Social SDK licensed to social robotics companies (e.g., Enchanted Tools) for integration into social and assistive robot platforms. Revenue model based on per-unit licensing or platform licensing agreements with robotics OEMs.
3. Healthcare / Clinical Software Licensing: Technology licensed for clinical applications including mental health triage, clinical trials biomarker tools, and remote consultations. The TrueBlue app, used in NHS-affiliated clinical studies, represents a potential subscription or per-user licensing model for healthcare providers.
4. Consumer Research / UX Research SDK: SDK for passive, granular emotional response measurement in consumer product testing, UX research, and media effectiveness studies. Likely commercialised as a SaaS subscription or usage-based licensing model.

Go-to-market motion3 records

Distribution channels5 records

Marketing channels7 records

Core offering

BlueSkeye AI builds on-edge face and voice analysis software that decodes social, emotional, and medical behaviour in real time (sub-130ms). Its portfolio includes the B-Automotive SDK for in-cabin driver/occupant monitoring and ADAS, the B-Social / B-Social 3 SDK for social and assistive robotics, and the TrueBlue App for perinatal mental health monitoring. The technology is licensed to automotive OEMs and Tier 1 suppliers, robotics OEMs, healthcare providers, and consumer/UX research organisations, with all inference running on-device and no biometric data sent to the cloud.

Product overview

BlueSkeye AI offers a portfolio of sector-specific software products built on a unified face and voice analysis platform. The core technology processes face and voice data entirely on-edge (no cloud transmission) to detect emotional states in under 130ms. The product family includes B-Automotive SDK for automotive driver/occupant monitoring and ADAS applications, B-Social/B-Social 3 SDK for social robotics applications, and the TrueBlue App for maternal mental health monitoring in healthcare. Core capabilities include face detection/tracking, eye gaze tracking, facial action unit analysis (46 units at 15fps), expressed emotion detection, visual voice activity tracking, multi-person processing, and re-identification. These modules can be deployed individually or combined depending on industry requirements across automotive, health, robotics, and consumer research sectors.

Differentiator

Problem solved

Functional benefit

Products and services

• B-Automotive SDK Software-only SDK delivering real-time on-edge social and emotional intelligence for automotive ADAS and Intelligent Cockpit programmes. Processes multimodal face and voice data to provide granular, continuous insights into driver and occupant expressed emotion, mood, drowsiness, and mental state, integrating with existing in-cabin NIR cameras on ARM, x86, Samsung Exynos, and NVIDIA Jetson automotive-grade chipsets.
• B-Social SDK SDK enabling social and assistive robots to perceive and interpret human social and emotional signals. Includes facial muscle analysis, user identification, oculometry, head pose estimation, and expressed emotion analysis for empathetic human-robot interaction. Addresses the cocktail-party problem (counting people, identifying speakers, addressees, topics, and engagement levels in group conversations).
• B-Social 3 SDK Advanced SDK for social robotics delivering facial muscle analysis, user identification, oculometry, head pose estimation, and expressed emotion analysis to enable robots to operate acceptably in shared human environments such as care, retail, and hospitality.
• TrueBlue App Smartphone application for perinatal maternal mental health monitoring that uses BlueSkeye's on-device face and voice analysis with a virtual human avatar (Kira) to capture objective, real-time measurements of mood for early detection and severity monitoring of depression and anxiety. Validated with Nottinghamshire Healthcare NHS Foundation Trust and the University of Nottingham.

Quantifiable outcome

• Detects emotional changes in less than 130ms — real-time inference with no cloud latency
• +4 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature11 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Enchanted ToolscoreStrategic or Co-development Partner · 8 January 2026Blueskeye AI and Enchanted Tools are partnering to refine socially intelligent interaction in social and assistive robots, beginning with Enchanted Tools' Mirokaï platform. Blueskeye AI's B-Social 3 SDK — including facial muscle analysis, user identification, oculometry, head pose estimation, and expressed emotion analysis — is being integrated to enable more empathetic, socially coherent human-robot interactions. Enchanted Tools develops people-facing social and assistive robots for healthcare (including ICM radiotherapy support for children) and senior living environments.
• University of NottinghamcoreStrategic or Co-development PartnerResearch partner in the TrueBlue Clinical Study, a collaborative initiative delivered with Nottinghamshire Healthcare NHS Foundation Trust. Blueskeye's face and voice analysis technology is used within the TrueBlue smartphone app to capture objective, real-time measurements of mood through subtle facial and vocal analysis. The study aims to prove the app is a safe and effective tool for early detection and severity monitoring of perinatal depression. The team won 1st Place Poster Presentation at RCOG Perinatal Mental Health Conference (March 2026).
• Nottinghamshire Healthcare NHS Foundation TrustcoreStrategic or Co-development PartnerClinical partner in the TrueBlue Clinical Study alongside the University of Nottingham. The Trust provides clinical oversight and NHS pathway validation for the Blueskeye AI-powered TrueBlue app, which uses a virtual human avatar named Kira to interact with mothers and mothers-to-be while capturing objective mood biomarkers through face and voice analysis. Dr Neil Nixon, Clinical Associate Professor in Adult Mood Disorder at the University of Nottingham/Nottinghamshire Healthcare NHS FT, is quoted as supporting the technology's potential to move beyond traditional clinical assessment.
• DATAcc by DiMe (Digital Medicine Society)minorStrategic or Co-development PartnerBlueskeye AI is listed as one of over 20 industry, advocacy, and research partners contributing to DATAcc by DiMe's first set of digital measures specifically designed for common mental health disorders. The seven measures include speech/language changes and facial/gaze features as clinical trial endpoints. The resource was commissioned by Wellcome and advances outcomes-based approaches in mental health treatment.

Scale indicators6 records

Recent moves6 records

Expansion highlights7 records

Direct peers

• Smart Eye: Swedish publicly-listed driver monitoring system specialist with multi-OEM production contracts across Europe, US, and Japan. Direct competitor to Blueskeye's B-Automotive SDK, operating in the same Euro NCAP 2026-driven DMS/OMS market with a much larger installed base and longer revenue history.
• Seeing Machines: Australian-listed DMS company with both aftermarket (Guardian) and embedded OEM business lines shipping into production vehicles. Competes head-to-head with Blueskeye in driver and occupant monitoring, with similar emotion/attention AI capabilities.
• Cipia: Israeli AI computer vision company focused exclusively on in-cabin sensing (DMS/OMS). Comparable product offering to Blueskeye's B-Automotive SDK and a direct competitor in OEM and Tier 1 sales processes globally.
• Affectiva (Xperi): Emotion AI pioneer acquired by Xperi, providing facial expression analysis for automotive cabin experience and media analytics. Overlaps directly with Blueskeye's expressed-emotion, facial action unit, and multi-person analysis capabilities across automotive and consumer research verticals.

Emerging players

• Eyeris: US-based in-cabin sensing AI company supplying Tier 1s with emotion, gaze, and occupant monitoring. Comparable technology stack and similar Tier 1/OEM go-to-market motion, though with a US rather than UK geographic anchor.
• Sonde Health: US-based vocal biomarker company detecting mental and physical health conditions from short voice samples. Comparable to Blueskeye's TrueBlue mental health monitoring concept, though Sonde focuses on voice-only biomarkers rather than multimodal face+voice.
• Ellipsis Health: Clinical-grade voice biomarker AI for anxiety and depression detection used in clinical workflows. Closest comparable to Blueskeye's NHS-affiliated TrueBlue programme from a clinical-deployment and mental-health-triage standpoint.
• Hume AI: US-based emotion AI company offering voice and facial expression analysis APIs for product/research use cases. Comparable to Blueskeye's emotion-detection and consumer-research SDK offerings, with broader developer-market distribution.

Broad incumbents

• Aptiv: Global Tier 1 automotive supplier with broad ADAS and cockpit portfolios. As a large incumbent, Aptiv could be either a Blueskeye customer (integrating the SDK into its cabin platform) or a competitor building similar in-house emotion AI capabilities.
• Continental: Major automotive Tier 1 with an established DMS/OMS product line and integrated cabin sensing offerings. Represents both potential customer and competitor depending on whether Blueskeye's SDK is integrated or displaced by Continental's in-house stack.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/BlueSkeyeAI
• LinkedInuk.linkedin.com/company/blueskeye-ai
• Instagraminstagram.com/blueskeye_ai

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds1 record

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BlueSkeye AI